Mode
Text Size
Log in / Sign up
N/A N=2 Prevention

Pilot Study Evaluating the Safety and Efficacy of a Patient-Specific Enteroatmospheric Fistula Isolation and Management Device Independent of Negative Pressure Wound Therapy

Fistula · Abdominal Injury · Negative Pressure Wound Therapy

Enrolled (actual)
2
Serious AEs
Results posted
Oct 2023
Primary outcome: Primary: Change in Inpatient Participant Pain Rating

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
3D printed EAF management device (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Andrew Bernard
Primary completion
Sep 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Inpatient Participant Pain Rating
PRIMARY
Change in Outpatient Participant Pain Rating
PRIMARY
Change in Inpatient Participant Mobility Assessment
PRIMARY
Change in Outpatient Participant Mobility Assessment
PRIMARY
Change in Number of Required Wound Dressing Changes - Inpatient
PRIMARY
Change in Number of Required Wound Dressing Changes - Outpatient
PRIMARY
Change in Perceived Usefulness - Inpatient
PRIMARY
Change in Perceived Usefulness - Outpatient
PRIMARY
Change in Perceived Ease of Use - Inpatient
PRIMARY
Change in Perceived Ease of Use - Outpatient
PRIMARY
Change in Average Time of Required Fistula-specific Dressing Changes - Inpatient
SECONDARY
Infection Rates
SECONDARY
Number of Observed Leakages
SECONDARY
Length of Stay
SECONDARY
Fistula Resolution Time
SECONDARY
Complication Occurrences

Summary

This study aims to assess the efficacy of a custom fitted device designed to isolate enteroatmospheric fistulas effluent independent of negative pressure wound therapy and to evaluate the effects on the device related to dressing changes, time required for dressing changes, management costs, and the ease of use.

Eligibility Criteria

Inclusion Criteria

  • Stable condition, as determined by attending physician
  • Has enteroatmospheric fistula (EAF) in the setting of open abdomen
  • EAF is determined to require surgical resolution

Exclusion Criteria

  • Unstable condition, as determined by attending physician
  • Significant risk of complication
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04978090). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search